These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22430887)

  • 1. Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn's disease-like condition of the pouch.
    Tang LY; Cai H; Navaneethan U; Boone JH; Rhodes SJ; Moore L; Rho H; de La Motte C; Queener E; Shen B
    Int J Colorectal Dis; 2012 Nov; 27(11):1455-63. PubMed ID: 22430887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis.
    Tyler AD; Milgrom R; Xu W; Stempak JM; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Silverberg MS
    Clin Gastroenterol Hepatol; 2012 May; 10(5):507-12.e1. PubMed ID: 21963956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
    J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
    Dendrinos KG; Becker JM; Stucchi AF; Saubermann LJ; LaMorte W; Farraye FA
    J Gastrointest Surg; 2006; 10(7):1060-4. PubMed ID: 16843878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.
    Forcione DG; Rosen MJ; Kisiel JB; Sands BE
    Gut; 2004 Aug; 53(8):1117-22. PubMed ID: 15247177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch.
    Cummings D; Cruise M; Lopez R; Roggenbuck D; Jairath V; Wang Y; Shen B; Rieder F
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1251-1259. PubMed ID: 30411391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis.
    Parsi MA; Shen B; Achkar JP; Remzi FF; Goldblum JR; Boone J; Lin D; Connor JT; Fazio VW; Lashner BA
    Gastroenterology; 2004 May; 126(5):1280-6. PubMed ID: 15131788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric Patients.
    Tang V; Valim C; Moman R; Richman A; Zhou J; Ramgopal V; Albert R; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):248-253. PubMed ID: 27111346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
    Goren I; Yahav L; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.
    Hui T; Landers C; Vasiliauskas E; Abreu M; Dubinsky M; Papadakis KA; Price J; Lin YC; Huiying Y; Targan S; Fleshner P
    Dis Colon Rectum; 2005 Jun; 48(6):1254-62. PubMed ID: 15868228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease.
    Kotze LM; Nisihara RM; Utiyama SR; Kotze PG; Theiss PM; Olandoski M
    Arq Gastroenterol; 2010; 47(3):242-5. PubMed ID: 21140083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn's disease and intestinal tuberculosis in India.
    Ghoshal UC; Ghoshal U; Singh H; Tiwari S
    J Postgrad Med; 2007; 53(3):166-70. PubMed ID: 17699989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
    Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
    Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
    Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
    Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP
    Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.
    Sendid B; Quinton JF; Charrier G; Goulet O; Cortot A; Grandbastien B; Poulain D; Colombel JF
    Am J Gastroenterol; 1998 Aug; 93(8):1306-10. PubMed ID: 9707056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
    Vandewalle-El Khoury P; Colombel JF; Joossens S; Standaert-Vitse A; Collot M; Halfvarson J; Ayadi A; Landers CJ; Vermeire S; Rutgeerts P; Targan SR; Chamaillard M; Mallet JM; Sendid B; Poulain D
    Am J Gastroenterol; 2008 Apr; 103(4):949-57. PubMed ID: 18047546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease.
    Bernstein CN; Orr K; Blanchard JF; Sargent M; Workman D
    Can J Gastroenterol; 2001 Aug; 15(8):499-504. PubMed ID: 11544532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.